SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS. Chen BY, Song J, Hu CL, Chen SB, et al. Blood 2020;135:2271-2285.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen BY, Song J, Hu CL, Chen SB, et al. SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS. Blood 2020;135:2271-2285.
PMID: 32202636